Cargando…

Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review

BACKGROUND: Patients with stage 5 chronic kidney disease (CKD5) collaborate with their clinicians when choosing their future treatment modality. Most elderly patients with CKD5 may only have two treatment options: dialysis or conservative kidney management (CKM). The objective of this systematic rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelbrecht, Buur Louise, Kristian, Madsen Jens, Inge, Eidemak, Elizabeth, Krarup, Guldager, Lauridsen Thomas, Helbo, Taasti Lena, Jeanette, Finderup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434727/
https://www.ncbi.nlm.nih.gov/pubmed/34507554
http://dx.doi.org/10.1186/s12882-021-02516-6
_version_ 1783751666076483584
author Engelbrecht, Buur Louise
Kristian, Madsen Jens
Inge, Eidemak
Elizabeth, Krarup
Guldager, Lauridsen Thomas
Helbo, Taasti Lena
Jeanette, Finderup
author_facet Engelbrecht, Buur Louise
Kristian, Madsen Jens
Inge, Eidemak
Elizabeth, Krarup
Guldager, Lauridsen Thomas
Helbo, Taasti Lena
Jeanette, Finderup
author_sort Engelbrecht, Buur Louise
collection PubMed
description BACKGROUND: Patients with stage 5 chronic kidney disease (CKD5) collaborate with their clinicians when choosing their future treatment modality. Most elderly patients with CKD5 may only have two treatment options: dialysis or conservative kidney management (CKM). The objective of this systematic review was to investigate whether CKM offers a quantity or quality of life benefit compared to dialysis for some patients with CKD5. METHODS: The databases MEDLINE, EMBASE, the Cochrane Library, and CINAHL were systematically searched for studies comparing patients with CKD5 who had chosen or were treated with either CKM or dialysis. The primary outcomes were mortality and quality of life (QoL). Hospitalization, symptom burden, and place of death were secondary outcomes. For studies reporting hazard ratios, pooled values were calculated, and forest plots conducted. RESULTS: Twenty-five primary studies, all observational, were identified. All studies reported an increased mortality in patients treated with CKM (pooled hazard ratio 0.47, 95 % confidence interval 0.34–0.65). For patients aged ≥ 80 years and for elderly individuals with comorbidities, results were ambiguous. In most studies, CKM seemed advantageous for QoL and secondary outcomes. Findings were limited by the heterogeneity of studies and biased outcomes favouring dialysis. CONCLUSIONS: In general, patients with CKD5 who have chosen or are on CKM live for a shorter time than patients who have chosen or are on dialysis. In patients aged ≥ 80 years old, and in elderly individuals with comorbidities, the survival benefits of dialysis seem to be lost. Regarding QoL, symptom burden, hospitalization, and place of death, CKM may have advantages. Higher quality studies are needed to guide patients and clinicians in the decision-making process. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02516-6.
format Online
Article
Text
id pubmed-8434727
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84347272021-09-13 Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review Engelbrecht, Buur Louise Kristian, Madsen Jens Inge, Eidemak Elizabeth, Krarup Guldager, Lauridsen Thomas Helbo, Taasti Lena Jeanette, Finderup BMC Nephrol Research BACKGROUND: Patients with stage 5 chronic kidney disease (CKD5) collaborate with their clinicians when choosing their future treatment modality. Most elderly patients with CKD5 may only have two treatment options: dialysis or conservative kidney management (CKM). The objective of this systematic review was to investigate whether CKM offers a quantity or quality of life benefit compared to dialysis for some patients with CKD5. METHODS: The databases MEDLINE, EMBASE, the Cochrane Library, and CINAHL were systematically searched for studies comparing patients with CKD5 who had chosen or were treated with either CKM or dialysis. The primary outcomes were mortality and quality of life (QoL). Hospitalization, symptom burden, and place of death were secondary outcomes. For studies reporting hazard ratios, pooled values were calculated, and forest plots conducted. RESULTS: Twenty-five primary studies, all observational, were identified. All studies reported an increased mortality in patients treated with CKM (pooled hazard ratio 0.47, 95 % confidence interval 0.34–0.65). For patients aged ≥ 80 years and for elderly individuals with comorbidities, results were ambiguous. In most studies, CKM seemed advantageous for QoL and secondary outcomes. Findings were limited by the heterogeneity of studies and biased outcomes favouring dialysis. CONCLUSIONS: In general, patients with CKD5 who have chosen or are on CKM live for a shorter time than patients who have chosen or are on dialysis. In patients aged ≥ 80 years old, and in elderly individuals with comorbidities, the survival benefits of dialysis seem to be lost. Regarding QoL, symptom burden, hospitalization, and place of death, CKM may have advantages. Higher quality studies are needed to guide patients and clinicians in the decision-making process. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02516-6. BioMed Central 2021-09-11 /pmc/articles/PMC8434727/ /pubmed/34507554 http://dx.doi.org/10.1186/s12882-021-02516-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Engelbrecht, Buur Louise
Kristian, Madsen Jens
Inge, Eidemak
Elizabeth, Krarup
Guldager, Lauridsen Thomas
Helbo, Taasti Lena
Jeanette, Finderup
Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review
title Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review
title_full Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review
title_fullStr Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review
title_full_unstemmed Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review
title_short Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review
title_sort does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? a systematic review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434727/
https://www.ncbi.nlm.nih.gov/pubmed/34507554
http://dx.doi.org/10.1186/s12882-021-02516-6
work_keys_str_mv AT engelbrechtbuurlouise doesconservativekidneymanagementofferaquantityorqualityoflifebenefitcomparedtodialysisasystematicreview
AT kristianmadsenjens doesconservativekidneymanagementofferaquantityorqualityoflifebenefitcomparedtodialysisasystematicreview
AT ingeeidemak doesconservativekidneymanagementofferaquantityorqualityoflifebenefitcomparedtodialysisasystematicreview
AT elizabethkrarup doesconservativekidneymanagementofferaquantityorqualityoflifebenefitcomparedtodialysisasystematicreview
AT guldagerlauridsenthomas doesconservativekidneymanagementofferaquantityorqualityoflifebenefitcomparedtodialysisasystematicreview
AT helbotaastilena doesconservativekidneymanagementofferaquantityorqualityoflifebenefitcomparedtodialysisasystematicreview
AT jeanettefinderup doesconservativekidneymanagementofferaquantityorqualityoflifebenefitcomparedtodialysisasystematicreview